End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.049 NZD | +2.08% |
|
0.00% | -59.17% |
05-07 | Rua Bioscience Extends Distribution Agreement with Germany's Nimbus Health | MT |
05-07 | Rua Bioscience Limited Extends Agreement with Nimbus Health in Germany | CI |
Business Summary
Sales per Business
NZD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Manufacturing
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +1,376.41% |
Sales per region
NZD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Zealand
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +1,376.41% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Naske
CEO | Chief Executive Officer | - | 19-01-31 |
Manu Caddie
FOU | Founder | - | 15-12-31 |
Liam Walker
DFI | Director of Finance/CFO | - | - |
Anna Stove
CHM | Chairman | - | 19-04-30 |
Jessika Nowak
CTO | Chief Tech/Sci/R&D Officer | - | 19-02-28 |
Emma McIldowie
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Barclay
BRD | Director/Board Member | - | 23-04-30 |
Anna Stove
CHM | Chairman | - | 19-04-30 |
Director/Board Member | - | 22-07-31 | |
Panapa Ehau
FOU | Founder | - | 15-12-31 |
Paul Naske
CEO | Chief Executive Officer | - | 19-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 158,136,265 | 83,728,337 ( 52.95 %) | 0 | 52.95 % |
Company contact information
![address Rua Bioscience Limited(RUA)](https://cdn.zonebourse.com/static/address/119082173.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-59.17% | 4.77M | |
+26.93% | 5.6B | |
-33.55% | 3.53B | |
-3.74% | 3.03B | |
-26.09% | 2.58B | |
-10.93% | 2.31B | |
+41.50% | 1.86B | |
+41.84% | 1.45B | |
+47.62% | 1.41B | |
-28.07% | 1.27B |
- Stock Market
- Equities
- RUA Stock
- Company Rua Bioscience Limited